Jabra Enhance Select M3 vs Otofonix Encore

The Jabra Enhance Select M3 is a premium OTC hearing aid priced at $1,995, earning an A grade with a SoundScore of 4.0/5 in our lab testing. This behind-the-ear device delivers strong overall performance, positioning it among the better-performing options in the OTC category. In our testing, the Enhance Select M3 showed notable strengths in speech clarity during quiet environments, scoring 3.8/5—a solid result that sits 0.95 points above the OTC category average. Music streaming quality also performs well at 2.8/5, which is 0.87 points above average for the category, though still mixed in absolute terms. Feedback handling is excellent at 4.6/5, ensuring stable performance during movement and daily activities. The device does show limitations in challenging listening environments. Speech in noise scored 1.3/5, which falls 0.18 points below the category average and represents a low absolute score. Users who frequently encounter noisy restaurants, busy social gatherings, or similar environments may find this a meaningful limitation. Own-voice comfort scored 2.7/5—above the category average by 0.18 points but only mixed in absolute terms. Consumers seeking strong performance in quieter settings with good music streaming capability may find the Enhance Select M3 appealing. However, shoppers should note that alternatives like the Sennheiser All Day Clear and Jabra Enhance Pro 20 at Costco offer comparable or higher scores at lower price points, potentially representing better overall value for budget-conscious buyers.

The Otofonix Encore is a budget-priced prescription hearing aid available for $295, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This behind-the-ear device ranks #37 of 39 in the Prescription Hearing Aid category, placing it in the bottom tier of its class. In our standardized testing, the Encore demonstrates one clear strength: excellent feedback handling at 4.7/5, which means users are unlikely to experience whistling or squealing during normal use. However, the device shows significant limitations in other areas. Speech intelligibility scores are low in both quiet (1.0/5) and noisy environments (1.0/5), falling 2.40 and 1.11 points below category averages respectively. Music streaming performance scored 0.0/5, indicating this device is not suitable for those who want to stream audio content. The Encore uses disposable batteries and comes in a traditional behind-the-ear style. Notably, our tuned fit testing showed a slight decrease in overall performance compared to the initial fit, with the normalized score dropping from 2.8/5 to 2.4/5. Own-voice comfort also declined substantially when moving to a more occluding coupling. At this price point, consumers may want to consider alternatives. The RxEars Rxi offers substantially better performance at a similar budget price point with a score of 4.07/5. The Otofonix Encore may appeal to buyers seeking a very low-cost entry into prescription hearing aids who prioritize feedback stability, but those needing reliable speech clarity or streaming capabilities should explore other options.